You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endostar

Showing 1 - 25 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostar and Envafolimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 24, 2023

Envafolimab Combined With Endostar and Concurrent

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
May 19, 2023

Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

Recruiting
  • Lung Squamous Cell Carcinoma
  • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
  • Yancheng, Jiangsu, China
    Yancheng Clinical College of Xuzhou Medical University
Mar 21, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Esophageal Trial in Nanjing ("Endostar", Liposo, cisplatin)

Terminated
  • Esophageal
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jul 28, 2022

Advanced Pancreatic Cancer Trial in Xuzhou (Envafolimab, Endostar, Nab paclitaxel)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Mar 18, 2022

Lung Tumors Trial (Envafolimab, Endostar)

Not yet recruiting
  • Lung Neoplasms
  • (no location specified)
Feb 8, 2022

Nasopharyngeal Carcinoma Trial in Nanchang (Endostar)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostar
  • Nanchang, Jiangxi, China
    Xiaochang Gong
Dec 15, 2021

Nasopharyngeal Carcinoma Trial in Nanning (endostar, DDP, IMRT)

Completed
  • Nasopharyngeal Carcinoma
  • endostar
  • +2 more
  • Nanning, Guangxi, China
    The First Affiliated Hospital of Guangxi Medical University
Jan 30, 2022

Non-Small-Cell Lung Cancer Trial in Jinan (Recombinant human endostatin (Endostar))

Recruiting
  • Non-Small-Cell Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Oct 8, 2022

Advanced or Metastatic NSCLC Trial in Shanghai (drug, device, combination product)

Not yet recruiting
  • Advanced or Metastatic NSCLC
  • Endostar
  • +2 more
  • Shanghai, Shanghai, China
    Lan Mu
Jun 29, 2021

Other Disorders of Soft Tissues Trial in Shanghai (Endostar (recombinant human endostatin injection), Chemotherapy AI)

Recruiting
  • Other Disorders of Soft Tissues
  • Endostar (recombinant human endostatin injection)
  • Chemotherapy AI
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 6, 2021

Low-grade Glioma, Pediatric Brain Tumor Trial in Beijing (combined therapy with rh-ES and CV)

Recruiting
  • Low-grade Glioma
  • Pediatric Brain Tumor
  • combined therapy with rh-ES and CV
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Feb 10, 2022

Nasopharyngeal Carcinoma Trial in China (Endostatins, IMRT)

Unknown status
  • Nasopharyngeal Carcinoma
  • Foshan, Guangdong, China
  • +7 more
Jan 31, 2021

Malignant Pleural Effusion Trial in Shanghai (ENDOSTAR,cisplatin, Placebo , cisplatin)

Not yet recruiting
  • Malignant Pleural Effusion
  • Shanghai, China
    Xiaoying Wang
May 31, 2021

Nasopharyngeal Tumors Trial (endostar, intensity modulated radiation, cisplatin)

Completed
  • Nasopharyngeal Neoplasms
  • endostar
  • +2 more
  • (no location specified)
Jun 22, 2020

Nasopharyngeal Carcinoma Trial (Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy, IC+CCRT)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy
  • IC＋CCRT
  • (no location specified)
Jun 24, 2020

Mucosal Melanoma Trial in Shanghai (Toripalimab, chemo in combination with Endostar)

Recruiting
  • Mucosal Melanoma
  • Shanghai, Shanghai, China
    Zhiguo Luo
Jul 12, 2020

NSCLC Trial in Beijing (Camrelizumab)

Unknown status
  • Non-small Cell Lung Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 9, 2020

Lung Cancer Trial (Recombinant human endostatin (Endostar), Thoracic irradiation of 50 Gy with 3DCRT or IMRT)

Not yet recruiting
  • Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Thoracic irradiation of 50 Gy with 3DCRT or IMRT
  • (no location specified)
Oct 27, 2020

Soft Tissue Sarcoma, Adult, Stage IIB Trial in Tianjin (Endostar, Placebo, AIM regimen / GT regimen)

Completed
  • Soft Tissue Sarcoma, Adult, Stage IIB
  • Endostar
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Hospital & Institute
Dec 23, 2019

Patients With Esophageal Cancer(?-?) Trial in Xi'an, (endostar+chemoradiotherapy, chemoradiotherapy)

Unknown status
  • Patients With Esophageal Cancer(Ⅱ-Ⅲ)
  • Xi'an,, Shanxi, China
    The second affiliated Hospital of Xi'an Jiaotong University
Nov 22, 2019

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Paclitaxel+Nedaplatin+Endostar)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2019

Endostar Combined With Concurrent Radiochemotherapy for

Not yet recruiting
  • Unresectable Stage III NSCLC
    • (no location specified)
    Nov 12, 2019

    Non-squamous NSCLC Trial in Chongqing (endostar/PD-1 inhibitor, endostar)

    Unknown status
    • Non-squamous Non-small Cell Lung Cancer
    • endostar/PD-1 inhibitor
    • endostar
    • Chongqing, Chongqing, China
      Daping Hospital, Third Military Medical University
    Aug 19, 2019